Eating habits and sleep quality in individuals with type 1 diabetes on continuous glucose monitoring and insulin pump

Nutr Metab Cardiovasc Dis. 2024 Jul;34(7):1703-1711. doi: 10.1016/j.numecd.2024.03.006. Epub 2024 Mar 8.

Abstract

Background and aims: Sleep disorders are bidirectionally linked with eating behaviors and glucose metabolism, which could be clinically relevant in type 1 diabetes (T1D). We investigated the relationship between dietary habits and sleep quality in individuals with T1D on insulin pumps and continuous glucose monitoring (CGM).

Methods and results: In a cross-sectional study, dietary habits (7-day food diary, EPIC questionnaire) and sleep quality (Pittsburgh Sleep Quality Index questionnaire) were assessed in 59 men and 58 women with T1D, aged 19-79 years, using CGM and insulin pump. Differences in dietary habits and blood glucose after dinner (6 h) between participants differing in sleep quality, sleep duration, and sleep onset latency were evaluated. Bad Sleepers (n = 81) were twice as prevalent as Good Sleepers (n = 36) and had a significantly higher intake of fat than Good Sleepers (dinner: 30.7 ± 10.7 vs. 24.0 ± 10.5 g, p = 0.004). Short sleepers had a significantly higher usual intake (g/1000 kcal) of coffee and tea (90.4 ± 71.7 vs. 62.0 ± 35.6), alcoholic (47.8 ± 51.1 vs. 28.9 ± 31.5) and carbonated beverages (21.8 ± 38.1 vs. 9.3 ± 17.2) (p < 0.05 for all) than Long Sleepers. Long Sleep Onset Latency was associated with a significantly higher fat intake at dinner (41.8 ± 7.4 vs. 38.1 ± 9.1 % total energy, p = 0.029) than Short Sleep Onset Latency. No significant differences in post-dinner blood glucose levels were detected between participants with good or bad sleep quality.

Conclusion: Sleep disruption is common in T1D and is associated with unhealthy dietary choices, especially at dinner, independently of post-dinner blood glucose control.

Keywords: Continuous glucose monitoring; Dietary habits; Sleep onset latency; Sleep quality; Type 1 diabetes.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Blood Glucose Self-Monitoring* / instrumentation
  • Blood Glucose* / metabolism
  • Continuous Glucose Monitoring
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 1* / blood
  • Diabetes Mellitus, Type 1* / diagnosis
  • Diabetes Mellitus, Type 1* / drug therapy
  • Diabetes Mellitus, Type 1* / physiopathology
  • Feeding Behavior*
  • Female
  • Glycemic Control*
  • Humans
  • Hypoglycemic Agents* / administration & dosage
  • Insulin Infusion Systems*
  • Insulin* / blood
  • Male
  • Middle Aged
  • Postprandial Period
  • Risk Factors
  • Sleep
  • Sleep Quality*
  • Sleep Wake Disorders / blood
  • Sleep Wake Disorders / diagnosis
  • Sleep Wake Disorders / epidemiology
  • Sleep Wake Disorders / physiopathology
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Blood Glucose
  • Insulin
  • Hypoglycemic Agents
  • Biomarkers